Coevolution of COVID-19 research and China’s policies

被引:0
作者
Xi Cheng
Li Tang
Maotian Zhou
Guoyan Wang
机构
[1] Soochow University,Department of Digital Communication
[2] Fudan University,Department of Public Administration
[3] Emory University,School of Medicine
来源
Health Research Policy and Systems | / 19卷
关键词
Science and policy; Coevolution model; COVID-19; China;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 362 条
[1]  
Abd-Alrazaq A(2021)A comprehensive overview of the COVID-19 literature: machine learning-based bibliometric analysis J Med Internet Res 23 e23703-113423
[2]  
Schneider J(2020)Understanding the policy dynamics of COVID-19 in the UK: early findings from interviews with policy makers and health care professionals Soc Sci Med 1982 113423-50
[3]  
Mifsud B(2018)A brief history of evidence-based policy Annals Am Acad Polit Social Sci 678 40-94
[4]  
Alam T(2019)The problems of commissioned oral history: the swine flu 'crisis' of 2009 Oral Hist 47 86-e208857
[5]  
Househ M(2020)Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial JAMA Netw Open 3 e208857-11
[6]  
Hamdi M(2017)Model-based policymaking: a framework to promote ethical “good practice” in mathematical modeling for public health policymaking Front Public Health 5 68-2152
[7]  
Shah Z(2017)Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy? Health Res Policy Syst 15 1-12557
[8]  
Atkinson P(2020)Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel Real-time reverse transcription-PCR assay validated in vitro and with clinical specimens J Clin Microbiol 45 2138-114
[9]  
Gobat N(2016)An institutionalized policy-making mechanism: China’s return to techno-industrial policy Res Policy 24 12545-710
[10]  
Lant S(2020)Same pandemic but different studies: an exploration of COVID-19 research at the early stage Eur Rev Med Pharmacol Sci 43 102-53